2015 Agenda

Molecular Diagnostics: The Shift to Complexity

April 17, 2015; 8:30 am-5:00pm

 

Workshop Agenda

 

8:30-8:45         Workshop Welcome, Objectives and Introductions

Gary Marchant, Sandra Day O’Connor College of Law, ASU

 

8:45-9:15         The Shift to Multiplexity

George Poste, Center for Complex Adaptive Systems, ASU

 

9:15- 9:45        Case Study: HealthTell

Neal Woodbury, Biodesign Institute, ASU

 

9:45-10:10       Roundtable Discussion (Chaired by Rachel Lindor)

 

10:10-10:15     ASU’s new School of Biomedical Diagnostics

Mara Aspinall, ASU

 

10:15-10:30     Coffee Break

 

10:30-11:00     FDA Initiatives

Alberto Gutierrez, Director of the Office of In Vitro Diagnostics, FDA

 

11:00-11:30     Roundtable Discussion (Chaired by Rachel Lindor)

 

11:30-12:00     CMS Initiatives

Tamara Syrek Jensen, Director, Coverage and Analysis Group, CMS

 

12:00-12:30     Roundtable Discussion (Chaired by Rachel Lindor)

 

12:30-1:15       Lunch

 

1:15-1:45         Molecular Diagnostics Regulation: Where Do We Go From Here?

David Feigal, NDA Partners (former Director of FDA CDRH)

 

1:45-2:15         Congressional Initiatives

Ralph Hall, University of Minnesota School of Law

 

2:15-2:45         Roundtable Discussion (Chaired by Gary Marchant)

 

2:45-3:00         Coffee Break

 

3:00-5:00         Continue Roundtable Discussion on Solutions (Chaired by Gary Marchant)

 

 


 Presented by:

Law Center wordmark_LSI

 

Comments are closed.